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Chlamydia Infection Across Host
Species Boundaries Promotes
Distinct Sets of Transcribed
Anti-Apoptotic Factors
Joshua E. Messinger, Emmalin Nelton, Colleen Feeney and David C. Gondek*
Department of Biology, Ithaca College, Ithaca, NY, USA
Chlamydiae, obligate intracellular bacteria, cause significant human and veterinary
associated diseases. Having emerged an estimated 700-million years ago, these bacteria
have twice adapted to humans as a host species, causing sexually transmitted infection
(C. trachomatis) and respiratory associated disease (C. pneumoniae). The principle
mechanism of host cell defense against these intracellular bacteria is the induction of
cell death via apoptosis. However, in the “arms race” of co-evolution, Chlamydiae have
developed mechanisms to promote cell viability and inhibit cell death. Herein we examine
the impact of Chlamydiae infection across multiple host species on transcription of
anti-apoptotic genes. We found mostly distinct patterns of gene expression (Mcl1 and
cIAPs) elicited by each pathogen-host pair indicating Chlamydiae infection across host
species boundaries does not induce a universally shared host response. Understanding
species specific host-pathogen interactions is paramount to deciphering how potential
pathogens become emerging diseases.
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INTRODUCTION
Bacterial pathogens have co-evolved with their hosts, subverting host cell biology through secreted
virulence factors to maintain a niche for pathogen growth. Chlamydiae, obligate intracellular
gram-negative bacterial pathogens, have evolved from a common progenitor to become infectious
specialists for a variety of host species (Nunes and Gomes, 2014). Two Chlamydia species, C.
trachomatis and C. pneumoniae, predominate human infection. C. trachomatis infects epithelial
cells of the reproductive tract, making it the number one bacterial sexually transmitted disease while
C. pneumoniae can cause respiratory and in some cases atherosclerotic disorders (Campbell and
Kuo, 2004; Starnbach and Roan, 2008). Chlamydiae replicate within an intracellular compartment
called the inclusion. To maintain this replicative cellular niche, Chlamydiae have evolved
mechanisms to prevent host cell death, one in particular being the inhibition of apoptosis.
Apoptosis is an organized mechanism of cellular death triggered through either an extrinsic
pathway (death receptor signaling) or a cellular intrinsic pathway (mitochondrial breakdown). A
common feature in both these pathways is the activation of cytosolic proteases, called caspases
(Thornberry and Lazebnik, 1998). While the extrinsic pathway activates caspases directly, the
intrinsic pathway requires destabilization of the mitochondrial membrane, mediated by pro-
apoptotic proteins such as Bax, Bak, and Bad, leading to the release of cytochrome C. The
pro-apoptotic proteins can be held in check by cellular anti-apoptotic factors such as Bcl-2, Mcl-1,
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and cIAP. Both the intrinsic and extrinsic apoptosis
pathways of apoptosis result in nuclear fragmentation
and organized dispersal of cellular contents via membrane
blebbing.
Intracellular bacterial infection requires host cell survival.
Previous studies have shown that Chlamydia infection results
in the inhibition of the host cell apoptotic response under
a variety of conditions (Fan et al., 1998). Chlamydia can
inhibit the cleavage of pro-apoptotic proteins (Xiao et al.,
2004). Infection can also cause the upregulation of host anti-
apoptotic factors such as MCL1 and IAP complexes (Rajalingam
et al., 2006, 2008). However, conflicting reports exist in the
literature regarding the impact of these anti-apoptotic factors.
For example, Chlamydia trachomatis infection of human cells
requires cIAP complexes, whereas these complexes are not
essential for infection of mouse cells by this same pathogen (Ying
et al., 2008).
To address this discrepancy, we took an evolutionary
medicine approach. The infectious process places significant
genomic pressures on both the pathogen and the host in the
“arms race” of co-evolution (Red Queen Hypothesis) (Van Valen,
1973). This hypothesis captures the idea that as the host evolves
mechanisms to sense infection and eliminate the invader, the
pathogen is coordinately evolving mechanisms to shut down
those host processes. Since the radiation of Chlamydiae has
occurred over the past few million years, it is likely that each
pathogen species has evolved host specific adaptations to ensure
survival (Borges et al., 2012). Cellular apoptosis is a highly
conserved mechanism for combating intracellular infection
and Chlamydiae have been shown to repress this response in
cells upon infection. However, there is no evidence that all
Chlamydiae use the same anti-apoptotic mechanism to reach that
outcome.
Here we show that Chlamydiae infection directly impacts host
transcriptional levels of anti-apoptotic proteins. The addition
of cycloheximide (CHX), a eukaryotic translational inhibitor,
significantly impacts this host transcriptional profile, indicating a
potential positive feedback loop of anti-apoptotic gene activation
elicited by the pathogen. Utilizing three separate Chlamydiaceae
(C. trachomatis-Ct, C. muridarum-Cm, C. caviae-Cc) and
multiple host cell lines (human, mouse, guinea pig, monkey,
and cat) we identify that each pathogen induces a unique
anti-apoptotic transcriptional response dependent upon host
species infection. Examining the host pathogen interactions and
comparing infections will allow us to understand the boundaries
for cross species infectivity. This insight is key to unraveling the
evolution of new and emerging disease.
METHODS
Cell Culture and Chlamydiae Stocks
McCoy (mouse fibroblast) and 104C1 (guinea pig lung fibroblast)
cells were maintained in RPMI media supplemented with 10%
FBS (Atlanta Biologics), L-glutamine, HEPES buffer, and β-
mercaptoethanol. Vero (African green monkey kidney) and
HeLa (Human endocervical) cells were maintained in Dulbecco’s
Modified Eagles Medium (DMEM) supplemented with 10%
FBS plus additional components listed above. AK-D (Cat
lung fibroblast) cells were maintained in Hams-F12 media
with 10% FBS plus additional components above. All cells
were grown at 37◦C with 5% CO2. Chlamydia trachomatis
(L2/434Bu and D/UW-3/CX), Chlamydia muridarum (MoPN),
and Chalmydiophila caviae (GPIC) bacterial stocks were
purified over a renografin gradient, resuspended in sodium
phosphate glutamate (SPG) and stored at −80◦C. To titer
stocks, purified Chlamydiae were serial diluted on McCoy
cells and centrifuged for 1 h at 1500RCF at 37◦C. Cells were
incubated for 30 h in media containing cycloheximide (CHX)
(1.5µg/mL) prior to fixation and staining. C. trachmoatis
and C. muridarum strains were generously provided by the
Starnbach Lab (Harvard Med) and C. caviae was purchased from
ATCC.
Immunofluorescent Staining
After overnight methanol fixation, cells were rehydrated and
stained with primary antibody (αHsp60—Thermo A57B9),
secondary antibody (AlexaFluor A11032) and Hoechst 33258 or
DAPI. Immunofluorescent stains were imaged using a Nikon
Eclipse E800 UV microscope with a Nikon DS-Ri1 camera
adapter. Images were analyzed with Nikon NIS-Elements D
imaging software. For quantification and unbiased analysis
of infectous units per milliliter images were processed using
MATLAB image processing toolbox (mathworks.com). Within
MATLAB, a script was written to batch convert images to
grayscale, uniformly threshold the images, and then count
numbers of inclusions (dots) per image. Data were exported to
Excel for further analysis and quantification of infectious units
per milliliter of lysate.
Recoverable Infectious Unit Assay
Confluent monolayers of McCoy, 104C1, AK-D, Vero, and
HeLa cells were plated on Costar tissue culture 24 well plates
for overnight growth in the conditions mentioned above.
Monolayers were infected at an MOI of approximately one
(1 × 105 IFU) by C. trachomatis, C. caviae, and C. muridarum
in media by centrifugation at 37◦C at 1500 RCF for 1 h.
Media was changed and the Chlamydia were allowed to grow
in the presence or absence of CHX (1.5µg/ml) at 37◦C. At
30 h post infection media was collected into a new Costar
24 well plate and cells were hypotonically lysed using sterile
water. Lysates were vigorously pipetted prior to being combined
with the spent media and the mixture was frozen at −80◦C
to ensure freeze fracture of infected cells. Cell lysates were
serial diluted in SPG over confluent monolayers of McCoy
cells in Costar 96-well plates and were centrifuged as described
above.
Cell Death and Apoptosis Assay
Confluent monolayers of McCoy, HeLa, and 104C1 cells were
plated on Costar 96-well tissue culture plates for overnight
growth. Cells were infected with C. trachomatis at an MOI of
approximately five, or C. caviae or C. muridarum at an MOI
of approximately two in SPG using centrifugation as previously
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described (Coers et al., 2011). Following centrifugation, media
was replaced with or without CHX (1.5µg/ml) and allowed to
incubate at 37◦C for 30 h. At 36 h post infection, cells were
challenged with staurosporine (104C1–25µM, McCoy–10µM,
HeLa–2µM) and allowed to incubate for 4 h at 37◦C. Cells were
then stained for immunofluorescence microscopy as described
above.
Gene Expression Analysis by RT-qPCR
Genomic sequences for the following genes were obtained
through the Ensembl bioinformatic database (ensemble.org).
All known isoforms were analyzed and the primer binding
sites that were flanking exon boundaries were determined for
shared exons in all isoforms. Upon identifying exon boundaries,
these sequences were entered into PRIMER3 (http://bioinfo.
ut.ee/primer3/) to determine thermodynamically ideal primers
for RT-qPCR(see table below) of genes previously identified as
modulated by Chlamydia infection (Wahl et al., 2003; Rajalingam
et al., 2006, 2008; Kun et al., 2013). Confluent monolayers of
McCoy, HeLa, and Guinea Pig cells were plated in Costar six
well tissue culture treated plates for overnight growth. Cells were
infected at an MOI of approximately five for C. trachomatis and
an MOI of approximately two for C. caviae and C. muridarum.
At 30 h post infection, media was aspirated, cells washed, and
lysed directly in the plate for total RNA isolation as directed
by the Omega Biotech Total RNA Isolation Kit. RNA was
stored at −80◦C before analysis through RT-qPCR. All 1-step
RT-qPCR reactions (Quanta BioSciences) were generated as
directed by the manufacturer and analyzed on a Roche454
Lightcycler.
Primer Sequences Used in this Study
Forward 5′—3′ Reverse 5′—3′ Product
Guinea pig cIAP1 GCCATCTACGGTTCCAATTC CACCATCACAGCAAAAGCAT 97
cIAP2 Gene is not annotated in database
Bcl2 TCCCAGAGAGGCTACGAGTG ACACCAAGCGGGGAGTTG 109
Mcl1 CACCAGCAGGAAGGCACT ATGTCCAGTTTCCGAAGCAT 96
Survivin GAACTGGCCCTTCGTGAAC AAGAAACACTGCGCCAAATC 107
XIAP TTGGGACATGGACGTATTCA TCCTCCTCCACAGTGAAAGC 103
GAPDH CCTAATGTGTCGGTTGTGGA TGTTGAAGTCACAGGACACAA 150
Mouse cIAP1 GTTGTGATGGTGGCTTGAGA CTCCTGACCCTTCATCCGTA 106
cIAP2 GGGGAGTTCCTGTGTCAGAA TGTCTAGCATCAGGCCACAG 101
Bcl2 AGTACCTGAACCGGCATCTG CAGCCAGGAGAAATCAAACAG 109
Mcl1 TGTAAGGACGAAACGGGACT ATTTCTGATGCCGCCTTCTA 98
Survivin ATCGCCACCTTCAAGAACTG AATCAGGCTCGTTCTCGGTA 105
XIAP TGGAACATGGACATCCTCAG CCTCCACAGTGAAAGCACTTC 98
GAPDH CAATGTGTCCGTCGTGGA GTTGAAGTCGCAGGAGACAAC 147
Human cIAP1 TGCGGCCAACATCTTCAAAA CGTTCTTCTTGCAACCTCCTC 150
cIAP2 TGGGTTCAACATGCCAAGTG TCATCTCCTGGGCTGTCTGA 140
Bcl2 AGTACCTGAACCGGCATCTG CAGCCAGGAGAAATCAAACAG 119
Mcl1 CTTACGACGGGTTGGGGATG GCGGAAACAATGACTCATGGC 150
XIAP TGGCAGATTATGAAGCACGGA TAGCCCTCCTCCACAGTGAA 137
GAPDH AACGGGAAGCTTGTCATCAATGGAAA GCATCAGCAGAGGGGGCAGAG 194
Caspase-3 Colorimetric Absorbance Assay
Cells were plated into six well plates (5∗105 per well) for overnight
growth. Cells were infected as described above. Twenty-six hours
post infection cells were left either untreated or treated with
staurosporine for 4 h prior to collection. Cells were probed for
caspase three activity using the commercially available Caspase-
3 Cellular assay kit PLUS (Enzo Life Sciences). Absorbance
readings at 405 nm were made every 10min for 6 h using a
TECAN NanoQuant infinite M200 Pro plate reader.
Statistical Analysis
All experiments were independently replicated two ormore times
as noted in figure legends. Statistical significance was determined
via One-way ANOVA and Tukey’s post-hoc pairwise comparison
test. P-values less than 0.05 were used to determine significant
data.
RESULTS
Chlamydiae Infection and Growth Across
Host Species Boundaries
A pathogen and its host are under constant genomic pressure
as the duo are locked in coevolutionary arms race of adaptation
(Red Queen Hypothesis; Van Valen, 1973). Upon infection,
pathogen recognition receptors (NOD/TLR) are stimulated in
the cell leading to changes in gene transcription and protein
activation (O’Connell et al., 2006). These pathways can elicit the
production of new proteins which result in pathogen elimination
and/or cell apoptosis. Chlamydiae have adapted host-specific
mechanisms to subvert this cellular response by modulating
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the host response to infection at a transcriptional and post-
translational level (Hess et al., 2001; Olive et al., 2014).
Cycloheximide (CHX) is a commonly used eukaryotic
translation inhibitor that improves the growth of Chlamydia
by reducing competition for intracellular amino acids (Allan
and Pearce, 1983b). Thus, this treatment is able to improve
the growth of poorly host adapted pathogens. A well-adapted
pathogen would not need this “advantage.” Moreover, this CHX
block of host cell translation could inhibit Chlamydia’s ability
to manipulate the infected host cell. We hypothesized that host
adapted Chlamydia relies on active host cell translation to reach
maximal growth potential. To test this, we examined the impact
of CHX on the ability to enhance or inhibit pathogen growth
across host species boundaries. We infected the following five
host cell lines with each pathogen (Ct, Cc, and Cm): mouse,
monkey, cat, human, and guinea pig. To compare growth
potential, we took the ratio of total infectious progeny in the
absence vs. presence of CHX such that a positive correlation
indicates improved growth due to ongoing host translation. We
found that only Cm in the guinea pig cell line was able to
FIGURE 1 | Enhanced growth in the presence of host cell
translation—Cells were infected in 24 well plates (105 cells/well) for
30h with or without CHX (1.5µg/mL). Supernatants of hypotonically lysed
cells were clarified by centrifugation and titered. Chlamydiae were stained with
α-HSP60 to quantitate infectious units/ml (A). Presented is the ratio of
(-CHX/CHX). Growth curves of Cm and Ct (MOI = 1 at 1× 105 IFU) were
determined in mouse and guinea pig cells (Gray line-Cm, solid line-Ct, dashed
line-Cc open marker—guinea pig, solid marker—mouse) (B). Ct-C.
trachomatis, Cc-C.caviae Cm-C.muridarum. *p < 0.05 (data are representative
of two independent trials).
grow significantly better in the presence of host cell translation,
compared to Ct and Cc (p < 0.05; Figure 1A).
To determine if this high infectious load in guinea pig cells is
a result of a more rapid conversion to the infectious elementary
body, we compared Cm and Ct growth in guinea pig to that in
mouse cells (Figure 1B). The Chlamydia IFU production during
Cm infection appeared to be more rapid than Ct or Cc infection.
Cm loads were similar between guinea pig and mouse cell lines
across all time points. For Ct and Cc, infections of the Guinea
Pig cell line typically yielded one log lower IFU at 30 h post
infection, compared to McCoy cell infection. Additionally, Cm
demonstrated high bacterial loads in all host species cell lines
tested compared to Ct and Cc infections (Supplemental Figure 1).
Apoptosis Inhibition is a Key Determinant
of Chlamydiae Growth Potential
In experiments where Chlamydiae growth potential was
particularly poor, cells examined by microscopy displayed
cellular blebbing and a significant debris field, indicative of
apoptosis (Supplemental Figure 2C). As maintenance of host cell
viability is absolutely critical for success of obligate intracellular
bacteria, a host-adapted pathogen would be able to inhibit
cellular apoptosis. To test this hypothesis, we focused our studies
on mouse, human, and guinea pig host species. We infected each
host cell species with Chlamydiae followed by treatment with
staurosporine, to induce host cell apoptosis. We examined the
production of active caspase three and fragmentation of nuclei in
order to determine the extent of apoptosis inhibition. As shown
in Figure 2, cells infected with each species of Chlamydiae were
able to inhibit the activation of caspase three while uninfected
cells could not. Cm exhibited the most pronounced inhibitory
activity across host species boundaries, particularly in guinea
pig cells, whereas Cc was the most limited in its ability to block
caspase 3 activity.
To determine the extent to which Chlamydiae infection could
impede nuclear fragmentation during apoptosis, cells were co-
stained to identify both Chlamydiae inclusions and nuclear
content (Figure 3). As shown in Figure 3B, when guinea pig
cells are treated with staurosporine nuclear condensation occurs
based on the observed increase in nuclear stain fluorescence and
fragmentation of the nuclear material (p < 0.01). However, when
these cells are infected with Chlamydiae the DNA fragmentation
is inhibited (Figures 3C–E, p < 0.05). Cc infected cells were
sparsely found on the slides due to apoptotic destruction of the
cell prior to labeling leading to large variability and inability
to image clusters of cells (Figure 3, Supplemental Figure 2C
and data not shown). Collectively, these data indicate that
Chlamydiae are able to inhibit the apoptosis of the host cell and
that the level of success for the pathogen is dependent upon the
species of host cell infected.
Chlamydiae Upregulate Anti-Apoptotic
Genes Unique to each Host-Pathogen
Combination
We have established that Chlamydiae are capable of inhibiting
apoptosis across multiple host species boundaries. However,
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FIGURE 2 | Chlamydiae inhibit Caspase three activation in diverse
hosts—Cell lines were infected with the indicated pathogens and
allowed to incubate for 26h. Staurosporine was added for 4 h before cell
lysates were collected for colorimetric analysis of caspase three activity in
mouse cells (A), human cells (B), and guinea pig cells (C). Ct-C. trachomatis,
Cc-C.caviae Cm-C.muridarum. **p < 0.01, *p < 0.05 (representative of greater
than three independent trials).
the importance of host derived anti-apoptotic gene regulation
during Chlamydiae infection has led to conflicting reports in
the literature. Rajalingam et al. indicate that IAP complexes
are highly upregulated in human cells following infection with
Ct and these complexes are necessary for infection. Whereas
Ying et al. report that Ct infection of mouse cells deficient
in these IAP genes are still fully capable of inhibiting cellular
apoptosis (Rajalingam et al., 2006; Ying et al., 2008). To rectify
these incongruous results, we examined the regulation of anti-
apoptotic transcripts in each of our host species cell lines when
infected by Chlamydiae. Based on our earlier finding that the
FIGURE 3 | Chlamydiae inhibit nuclear fragmentation induced by
staurosporine—Cell lines were plated on coverslips (A,B) or infected
with pathogens for 26h (C,D). Staurosporine was added for 4 h (B–D)
before cells were fixed and stained to visualize Chlamydiae (αHSP-60) and
DNA (Hoechst). White arrows indicate apoptotic cells. Percent apoptotic in
each of the treatment conditions is quantified (E). Ct-C. trachomatis,
Cc-C.caviae Cm-C.muridarum. **p < 0.01, *p < 0.05 (representative of four
independent trials).
absence of CHX improves bacterial growth in certain cell lines,
we decided to examine transcript levels in both the presence and
absence of CHX.
As was reported by Rajalingam, we identified an upregulation
of IAP genes following infection of human cells with the Ct
pathogen in both the presence and absence of CHX (Figure 4A).
Cm and Cc infections of human cells also follow a very similar
pattern of IAP regulation except these results are dependent
on CHX treatment (Figures 4B,C). In contrast to human cells,
infection of mouse cells with Ct or Cm were highly specific
for cIAP2 upregulation and this regulation was significantly
higher in cells which were actively able to translate host
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FIGURE 4 | Infection induced transcription of anti-apoptotic factors in the presence or absence of host translation. Cell lines were plated in six well plates
and infected for 30 h prior to lysis and RNA extraction. Relative expression was normalized to host GAPDH and then the ratio of infected vs. uninfected gene
expression was determined in human cells (A–C), mouse cells (D–F) and guinea pig cells (G–I). **p < 0.01, *p < 0.05 (representative of three independent trials).
proteins (Figures 4D,E). Cc infection of mouse or human cells
exhbited a marginal impact on the levels of antiapoptotic
transcripts (Figure 4F). Thus, the specific antiapoptotic gene
transcripts (and their regulation) are completely host species
dependent and are, in some cases, unique to the infecting
pathogen.
As described in Figure 1, Cm infection of guinea pig cells
was significantly improved by the absence of CHX. When we
examined the anti-apoptotic transcript expression level in these
cells we found that Cm infection casued a very prominent
upregulation, compared to Ct and Cc infection (Figures 4G–I).
In particular, Mcl1 was very highly upregulated in guinea pig
cells following Cm infection. Taken together, these data indicate
that each pathogen species has a unique ability to impact the host
transcription of anti-apoptotic genes. The quantity and diversity
of this regulation was pathogen-species specific and the pattern
of transcript expression was unique to each host species cell line.
DISCUSSION
Chlamydiae have been co-evolving with their hosts for the
last several hundred million years (Nunes and Gomes, 2014).
Throughout this time the competition between pathogen and
host has led to co-adaptation as the pathogen struggles to
maintain its intracellular replicative niche (Nunes et al., 2008).
Chlamydiae can be distinguished based on their specific amino
acid requirments with a level of specificity down to identification
of C. trachomatis biovars requirmeent for tryptophan(trachoma)
and methionine(LGV) supplementation of culture media (Allan
and Pearce, 1983a). The mechanisms for aquiring amino acids
can also be very different amongst Chlamydiae. In a direct
comparison to C. pneumoniae, Ct L2 was shown to be better
at accessing host amino acids in the presence of a lysosomal
inhibitor (Ouellette et al., 2011). The authors conclude that
C. pneumoniae and Ct L2 have inherent differences in their
mechanisms of amino acid acquisition. The addition of CHX
provides intracellular pathogens with reduced host competition
for nutrients and suppresses any de-novo protein production
the host may undertake in order to rid itself of the infection
(Ripa and Mårdh, 1977; Benes and McCormack, 1982; Sabet
et al., 1984; Harper et al., 2000). Under these optimal conditions,
in the absence of competition, Chlamydiae can readily infect
across host species boundaries. We asked if this “advantage”
was absolutely necessary for highly host adapted pathogens to
compete with the host for nutrients and, perhaps, the pathogen
could utilize the host’s own protein production to its advantage.
To test for different levels of human adaptation, we compared
two Ct pathogens which infect at the same site but have
markedly different infectious phenotypes. The invasive Ct LGV
strains exhibit rapid growth kinetics and capacity to infect
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systemically, as compared to the genital (or ocular) strains
(Miyairi et al., 2006). Based on these data, we hypothesized that
the LGV strains would be better at competing with the host
for nutrients and would not require CHX treatment for optimal
growth. Our data support this hypothesis since the provision
of “free” amino acids following CHX treatment exhibited a
marginal impact on LGV growth in HeLa cells as compared to
the Ct-D strain (Supplemental Figure 3). These data support
a similar finding when Ct-L2 was compared to Ct-E growth
in conditions ± CHX (Harper et al., 2000). Extending this
study to Chlamydiae infection across multiple host species of
cells, we found that only the Cm infection of guinea pig cells
demonstrated a unique species specific and significant growth
advantage from ongoing host cell translation, compared to Ct
and Cc infection (Figure 1A). In addition, Cm infection exhibits
some of the fastest growth kinetics and largest replicative burst
across multiple host species cell lines (Supplemental Figure 1).
From this we infer that Cm, despite being considered a mouse
specific Chlamydia pathogen, is actually a generalist due to
its highly permissive growth characteristics, with or without
CHX treatment. In contrast, Cc infections did particularly
poorly across multiple hosts indicating that it is the least well-
adapted to deal with the unique biology of these divergent host
species.
One main host mechanism to deny the pathogen further
growth potential is the organized cellular death pathway of
apoptosis. As such, the Chlamydiae pathogens have evolved
mechanisms to subvert this pathway and it has been the topic
of significant investigation for several years (Byrne and Ojcius,
2004). A thorough investigation of multiple Chlamydiae species
had previously identified a common capacity to inhibit apoptosis
in diverse tissue types of human cell lines (Greene et al.,
2003). We have extended these findings and demonstrate that
Chlamydiae can inhibit apoptosis across multiple host species
boundaries. We used activation of caspase three, the terminal
caspase in the proteolytic cascade, and nuclear fragmentation
as markers of apoptosis (Thornberry and Lazebnik, 1998). As
demonstrated in Figure 2, we corroborate those earlier reports
in that almost all Chlamydiae species are able to inhibit host cell
apoptosis. Intriguingly, Cc, the pathogen isolated from guinea
pigs, was the least capable to grow within guinea pig cells. Based
on light microscopy analysis, Cc infection of guinea pig cells
lead to significant membrane blebbing and apoptotic phenotypes
(Supplemental Figure 2). This led to particular problems in
acquiring Caspase 3 activity and nuclear condensation as the
cells were easily lost with gentle washing. The variability of Cc
infection in Figure 3E is due to this high rate of cell loss due
to combined infection and staurosporine induced apoptosis. In
most situations, Cc was the least capable of down regulating the
host Caspase 3 activity as compared to Ct or Cm infection within
each cell line (Figure 2).
The ability of Chlamydiae to subvert host cell apoptotic
responses could occur through two potential mechanisms,
modulation of intrinsic host cell anti-apoptotic responses or
through a direct impact on host cell biology via a type
three secreted virulence factor. The latter option has been
well studied in that Chlamydia post-translationally impact
BH3 domain pro-apoptotic proteins even in the presence of
CHX (Fan et al., 1998; Fischer et al., 2004; Pirbhai et al.,
2006). However, Chlamydia infection can also cause significant
changes in host cell transcription (Hess et al., 2001). These
changes to host cell biology could be induced through cellular
recognition of Chlamydia via pattern recognition receptors (such
as TLR2) or Raf/MEK signaling pathways (Su et al., 2003;
O’Connell et al., 2006). C. trachomatis has developed measures
to manipulate these signaling pathways, such as modulating
the host ubiquitination system necessary for NF-kB signaling
(Misaghi et al., 2006). NF-kB can upregulate proteins which
inhibit apoptosis (IAPs) and are critical for cell survival following
Ct infection (Rajalingam et al., 2006). RNAi inhibition of
these IAPs lead to a less permissive cellular niche and limited
replication of Chlamydia. Additionally, signaling through the
Raf/MEK pathway leads to an upregulation of anti-apoptotic
proteinMcl1 and Bag-1 (Rajalingam et al., 2008; Kun et al., 2013).
When Raf/MEK pathways were inhibited, Chlamydia infected
cells were highly susceptible to apoptosis induction. As an
alternative to manipulating cell signaling pathways, Chlamydiae
could use a type three secretion system (T3SS) to directly
inject the host cytosol with a bacterial protein which homes
to the eukaryotic nucleus and modifies host cell transcription.
Although its function is unknown, CT311 has recently been
demonstrated to contain a eukaryotic nuclear localization signal
(Lei et al., 2013). It is clear that infection withChlamydiae induces
significant anti-apoptotic gene transcriptional changes in a host
cell which can directly impact the viability of the host cell and its
resistance to apoptosis induction.
The importance of anti-apoptotic protein production during
Chlamydia infection has recently been called into question.
Studies with cell lines derived from mice deficient for these
IAPs indicate that the proteins are dispensable for the anti-
apoptotic effect (Ying et al., 2008). Discrepancies in host cell
species (human/mouse) and Chlamydia type were acknowledged
by both reports as confounding factors (Rajalingam et al., 2008;
Ying et al., 2008). To address the host species component of
these incongruous results, we examined the regulation of anti-
apoptotic transcripts in various host species cell lines across
multiple Chlamydiae pathogens. We identified that a single
host could respond differently to each Chlamydiae pathogen
(Figure 4). Differences in gene expression between hosts could be
due to host species differences or cell type differences. Therefore,
inter-host species comparisons are not a focus of this study. In
some cases the upregulation of anti-apoptotic protein transcripts
required ongoing host translation, indicating a potential positive
feedback loop induced by infection. Our transcriptional profile
data does support that conclusion in some cases where, in
the absence of CHX, anti-apoptotic protein transcripts are
significantly augmented (Figures 4D–H).We would surmise that
despite the similar outcome of blocked apoptosis, each pathogen
species reaches that goal via a potentially different mechanism.
Intriguingly, the mouse cell line predominantly upregulated a
single anti-apoptotic transcript, cIAP2, which was shown to be
dispensable (Ying et al., 2008). This would indicate that, in
mice, an alternative method for apoptosis inhibition could be
employed.
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Rather than rely solely on host cell signaling pathways for
the anti-apoptotic effect, evidence indicates that Chlamydiae
utilize a T3SS to inject bacterial proteins which directly impact
host cell biology. Early evidence indicated that Chlamydia could
induce proteolytic cleavage of pro-apoptotic BH3-only proteins
(Fischer et al., 2004; Zhong et al., 2006). This proteolysis
was attributed to the Chlamydia protease-like activity factor
(CPAF) (Pirbhai et al., 2006; Paschen et al., 2008) However,
the role of CPAF in this mechanism has been called into
doubt following the development of Chlamydia genetically
deficient for protease activity (Jorgensen et al., 2011; Snavely
et al., 2014). Moreover, this BH3 protein cleavage mechanism
was not reproducible (Rajalingam et al., 2008). The study of
pro-apoptotic BH3-only protein cleavage would also benefit
from an evolutionary approach to examining host-pathogen
interactions and address the discrepancies in these reported
systems.
Pathogens co-adapt with their hosts throughout evolution to
maintain their capacity for growth and dissemination. Similar
evolutionary medicine studies examining host specificity in
Salmonella infection have helped to identify key virulence factors
in host specificity (Bueno et al., 2008; Bäumler and Fang, 2013).
For Chlamydiae, the relatively small genomes add significant
evolutionary pressure due to gene loss, alternatively termed the
“use it or lose it” impact of adaptation (Nunes and Gomes,
2014). These host species-specific adaptations could impair the
pathogen’s ability to leap across species boundaries and emerge
as an infectious disease in a new host. However, data indicate one
such emergence has occurred fairly recently in humans with the
zoonotic acquisition C. pneumoniae, demonstrating Chlamydiae
are a good model for the study of emerging infectious disease
(Myers et al., 2009). The evolutionary medicine approach will
be highly informative to understanding the barriers for host
species-to-species pathogen transmission. The experiments in
this report begin to elucidate the potential mechanisms whereby
Chlamydiae are able to cross the species boundary and provide
a greater understanding of the barriers to emerging infectious
disease.
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